Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
NeoGenomics, Inc. (NEO) had Days Sales in Receivables of 75.36 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$190.17M |
|
$-9.88M |
|
$106.83M |
|
$83.34M |
|
$203.58M |
|
$-13.41M |
|
$1.01M |
|
$-12.41M |
|
$-12.41M |
|
$-9.88M |
|
$-9.88M |
|
$-9.88M |
|
$-9.88M |
|
$-13.41M |
|
$3.36M |
|
128.10M |
|
128.10M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$376.29M |
|
$84.83M |
|
$983.54M |
|
$1.36B |
|
$88.30M |
|
$341.86M |
|
$434.97M |
|
$523.27M |
|
$836.56M |
|
$25.69M |
|
$836.56M |
|
128.99M |
|
| Cash Flow Statement Financials | |
$5.23M |
|
$-12.34M |
|
$-200.29M |
|
$367.01M |
|
$159.62M |
|
$-207.39M |
|
$41.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.26 |
|
-- |
|
-- |
|
0.29 |
|
0.41 |
|
43.83% |
|
-7.05% |
|
-7.05% |
|
-- |
|
-6.52% |
|
-5.20% |
|
$-19.71M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
3.74 |
|
1.19 |
|
|
Days Sales in Receivables |
75.36 |
-1.18% |
|
-38.46% |
|
-0.73% |
|
-0.84% |
|
$6.49 |
|
$-0.15 |
|
$0.04 |
|